Owners of large dogs know an uncomfortable truth long before it arrives. A Great Dane might give them eight good years, maybe ...

Ghrelin is the “hunger hormone.” On binding with the ghrelin receptor, MK-677 stimulates the pituitary gland to release GH.

Merhi reportedly explained a procedure still considered experimental: an injection of platelet-rich plasma, or PRP, into the ...

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company committed to establishing tomorrow's standards of care in oncology and rare diseases, today announced that the first patient has ...

Argenx stock toppled Monday after the biotech scrapped plans to develop its blockbuster drug, Vyvgart, for thyroid eye ...

Debiopharm has randomised the first patient in the global Phase III clinical trial, OXTEND-III, to assess the safety and ...

The use of injectable peptides for a range of perceived health benefits is surging, fueled by aggressive marketing campaigns and miraculous claims from celebrities and influencers about their ability ...

Ming Yu was set up in 2018 by Cao Guoqing, a biochemist with an international profile in cutting-edge drug research. Cao ...

Scientists are developing a drug to slow ageing in senior dogs, particularly larger breeds prone to faster decline. This treatment targets growth horm ...

The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...